Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 28, Issue 33, Pages 4762-4772
Publisher
Baishideng Publishing Group Inc.
Online
2022-08-31
DOI
10.3748/wjg.v28.i33.4762
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
- (2022) Paul Feuerstadt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection
- (2021) Eric R. Littmann et al. Nature Communications
- How to Apply FMT More Effectively, Conveniently and Flexible – A Comparison of FMT Methods
- (2021) Adorján Varga et al. Frontiers in Cellular and Infection Microbiology
- Host Immune Responses to Clostridioides difficile: Toxins and Beyond
- (2021) Britt Nibbering et al. Frontiers in Microbiology
- A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Clostridioides difficile Infection
- (2021) Tanya M. Monaghan et al. Cells
- Healthy Human Gastrointestinal Microbiome: Composition and Function After a Decade of Exploration
- (2020) Wenly Ruan et al. DIGESTIVE DISEASES AND SCIENCES
- Considering the Immune System during Fecal Microbiota Transplantation for Clostridioides difficile Infection
- (2020) Alyse L. Frisbee et al. TRENDS IN MOLECULAR MEDICINE
- Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening
- (2020) Ting Zhang et al. Protein & Cell
- Insights into the Role of Human Gut Microbiota in Clostridioides difficile Infection
- (2020) Melina Kachrimanidou et al. Microorganisms
- Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology
- (2020) Alexander Khoruts et al. Nature Reviews Gastroenterology & Hepatology
- Clostridium difficile infection: review
- (2019) Jacek Czepiel et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
- (2019) Alyse L. Frisbee et al. Nature Communications
- Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis
- (2019) Hiroyuki Okumura et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
- (2019) Xinyang Song et al. NATURE
- Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection
- (2018) Anna M. Seekatz et al. ANAEROBE
- Development and Validation of a Prediction Model for Mortality and Adverse Outcomes Among Patients With Peripheral Eosinopenia on Admission for Clostridium difficile Infection
- (2018) Audrey S. Kulaylat et al. JAMA Surgery
- Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells
- (2018) Claudia Burrello et al. Nature Communications
- Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection
- (2017) Stephan J. Ott et al. GASTROENTEROLOGY
- Fecal Microbiota Transplantation
- (2017) Stephen M. Vindigni et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- European consensus conference on faecal microbiota transplantation in clinical practice
- (2017) Giovanni Cammarota et al. GUT
- Homeostatic Immunity and the Microbiota
- (2017) Yasmine Belkaid et al. IMMUNITY
- The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
- (2017) Sohn Kim et al. IMMUNOLOGICAL REVIEWS
- Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice
- (2017) Ira Ekmekciu et al. Frontiers in Immunology
- Faecal microbiota transplantation for Clostridium difficile infection using a lyophilized inoculum from non-related donors: A case series involving 19 patients
- (2017) Szabolcs Vigvári et al. ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA
- RecurrentClostridium difficileinfection associates with distinct bile acid and microbiome profiles
- (2016) J. R. Allegretti et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis
- (2016) Carlo De Salvo et al. AMERICAN JOURNAL OF PATHOLOGY
- Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
- (2016) Ilan Youngster et al. BMC Medicine
- Understanding the mechanisms of faecal microbiota transplantation
- (2016) Alexander Khoruts et al. Nature Reviews Gastroenterology & Hepatology
- Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection
- (2016) Erica L. Buonomo et al. Cell Reports
- The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia
- (2016) Carrie A. Cowardin et al. Nature Microbiology
- Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection
- (2015) Michael C. Abt et al. Cell Host & Microbe
- Interleukin-23 (IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation duringClostridium difficilecolitis in mice
- (2015) Andrew J. McDermott et al. IMMUNOLOGY
- Emergence of community-acquired Clostridium difficile infection: the experience of a French hospital and review of the literature
- (2015) Maja Ogielska et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review
- (2015) Noortje G Rossen WORLD JOURNAL OF GASTROENTEROLOGY
- Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection
- (2015) Alexa Weingarden et al. Microbiome
- Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR–S6K pathway
- (2014) J Park et al. Mucosal Immunology
- Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome
- (2014) Hao Xu et al. NATURE
- Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection
- (2013) Alexa R. Weingarden et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
- (2013) Katharine M. Ng et al. NATURE
- Can we identify patients at high risk of recurrent Clostridium difficile infection?
- (2012) C.P. Kelly CLINICAL MICROBIOLOGY AND INFECTION
- Defining the human microbiome
- (2012) Luke K Ursell et al. NUTRITION REVIEWS
- Treating Clostridium difficile Infection With Fecal Microbiota Transplantation
- (2011) Johan S. Bakken et al. Clinical Gastroenterology and Hepatology
- Nucleotide-Binding Oligomerization Domain 1 Mediates Recognition of Clostridium difficile and Induces Neutrophil Recruitment and Protection against the Pathogen
- (2011) M. Hasegawa et al. JOURNAL OF IMMUNOLOGY
- Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile
- (2010) M. C. Rea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
- (2010) K. Atarashi et al. SCIENCE
- Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
- (2008) K.W. Garey et al. JOURNAL OF HOSPITAL INFECTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started